专利号:US-11629137-B2 优先权日:2017-04-24 标 题:Methods of manufacturing of niraparib 发明人:STEWART ALISTAIR; TOTO ANTHONY JOSEPH; CHEN FRANK XING; WU GEORGE 权利人:TESARO INC 摘要:Disclosed herein are methods and processes of preparing niraparib and pharmaceutically acceptable salts thereof, and intermediates and their salts useful for the synthesis of niraparib.
专利号:WO-2024088910-A1 优先权日:2022-10-24 标 题 :Process for the preparation of a gadolinium contrast agent 发明人:HOG DANIEL; LONGERICH MARKUS; JACOBS TIA; GRUBE STEFAN; PLATZEK JONANNES; TERWILLIGER DANIEL WILLIAM; EBHARDT LASSE; BOEDDINGHAUS NICOLE; KUNELLIS JAN-CHRISTIAN; ULFERTS-HÄNEL ANITA; BALZER SANDRA; SCHIRMER HEIKO 权利人:BAYER AG 摘要:The present invention relates to a process for the preparation of a gadolinium chelate compound of formula (I) or its stereoisomers, tautomers, N-oxides, hydrates, solvates, or salts thereof, or mixtures of same. Further, the present invention relates to crystalline forms of the gadolinium chelate of formula (I), to a process for the preparation of said crystalline forms as well as to intermediate compounds in the synthesis of the gadolinium chelate compound of formula (I) and/or its crystalline forms as well as their stereoisomers, tautomers, N-oxides, hydrates, solvates, or salts thereof, or mixtures of same.
专利号:US-7994346-B2 优先权日:2001-11-06 标题 :Intermediates for the preparation of lipoxin A4 analogs 发明人:GROSSBACH DANJA; GUILFORD WILLIAM; SANDER MICHAEL 权利人:BAYER SCHERING PHARMA AG 摘要:This invention is directed to compounds useful as intermediates in the synthesis of lipoxin A 4 analogs of the following formulas (I) and (II): n nwherein R 1 , R 2 , R 3 , R 4 and R 5 are described herein. These analogs are useful in treating inflammatory and autoimmune disorders in humans. These analogs are also useful in treating pulmonary or respiratory tract inflammation in humans.
专利号:US-10611739-B2 优先权日:2016-08-16 标题:Process for preparation of lactone derivatives and intermediates thereof 发明人:CHEN PING; PENG SHAOPING; LI YINQIANG; LI DAFENG; DONG XUEJUN 权利人:PHARMARESOURCES SHANGHAI CO LTD 摘要:A novel process for the preparation of lactone derivatives, and intermediates thereof is described. The lactone derivatives are important precursors for the synthesis of anti-hepatitis C virus agents, including sofosbuvir.
专利号:US-2023158469-A1 优先权日:2021-11-01 标题 :Devices and methods for synthesis 发明人:LACKEY JEREMY; DODD DAVID; PITSCH STEFAN 权利人:TWIST BIOSCIENCE CORP 摘要:Provided herein are compositions, devices, systems and methods for DNA oligomer synthesis. Further provided are devices comprising addressable electrodes controlling polynucleotide synthesis (deprotection, extension, or cleavage, etc.). The compositions, devices, systems and methods described herein provide improved synthesis, storage, density, and retrieval of biomolecule-based information.
专利号:US-2022402908-A1 优先权日:2019-07-08 标题 :Cxcr6 inhibitors and methods of use 发明人:PEDDIBHOTLA SATYAMAHESHWAR; HERSHBERGER PAUL M; KIRBY RICHARD JASON; MALANY SIOBHAN; SMITH LAYTON H; MALONEY PATRICK R; SESSIONS HAMPTON; DIVLIANSKA DANIELA; PINKERTON ANTHONY B 权利人:SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INST 摘要:Provided herein are small molecule inhibitors of CXCR6 receptor, compositions comprising the compounds, and methods of using the compounds and compositions. The compounds are 9-azbicyclo[3.3.1]nonane or 9-diazbicyclo[3.3.1]nonane derivatives, whose synthesis is also described. Also provided are method of treating a disease or condition (such as, cancer) mediated by CXCR6/CXCL16 signaling pathway in a mammal.
参考文献:10.1021/jo016241m 摘要:Bach RD, Dmitrenko O. The effect of substitutents on the strain energies of small ring compounds. J Org Chem. 2002 Apr 19;67(8):2588–99. doi: 10.1021/jo016241m. 参考文献:10.1016/j.saa.2003.08.024|10.1016/s1386-1425(03)00414-1 摘要:Durig JR, Zheng C, Williams MJ, Stidham HD, Guirgis GA. Conformational stability from variable temperature infrared spectra of krypton solutions, ab initio calculations, vibrational assignment, and r0 structural parameters of 1,3-difluoropropane. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy. 2004 Jun;60(7):1659–76. doi: 10.1016/j.saa.2003.08.024.